"/> Novus Biologicals™ Peptide bloquant d’anticorps Bc… | B-LABO France

Novus Biologicals™ Peptide bloquant d’anticorps Bcl G

Réf. : BL-RE-048783Réf. fabricant : 18259625 0.05 mg
201,94 € HT

Highly purified. Generating reliable and reproducible results. Applications: Antibody Competition

Gene ID (Entrez)
79370
Espèces
Human
Contenu et stockage
Store at -20 C. Avoid freeze-thaw cycles.
Formule
PBS pH 7.2 (10 mM NaH2PO4, 10 mM Na2HPO4, 130 mM NaCl) containing 0.1% bovine serum albumin.
À utiliser avec (application)
This Peptide is Useful as a Blocking Peptide for NBP1-77223. For Further Blocking Peptide Related Protocol, Click Here .
Marque
Novus Biologicals

A blocking peptide containing 15 amino acids near the amino terminus of human Bcl-G.

Points forts

Source

Synthetic

(Accession #: NM_030766) The Bcl G Blocking Peptide has been validated for the following applications: Antibody Competition.

Caractéristiques techniques

MarqueNovus Biologicals
Réf. B-LABOBL-RE-048783
Réf. fabricant18259625
Gene ID (Entrez)79370
EspècesHuman
Contenu et stockageStore at -20 C. Avoid freeze-thaw cycles.
FormulePBS pH 7.2 (10 mM NaH2PO4, 10 mM Na2HPO4, 130 mM NaCl) containing 0.1% bovine serum albumin.
À utiliser avec (application)This Peptide is Useful as a Blocking Peptide for NBP1-77223. For Further Blocking Peptide Related Protocol, Click Here .
Alias de gèneapoptosis facilitator Bcl-2-like protein 14, Apoptosis regulator Bcl-G, Bcl2-L-14, BCL2-like 14 (apoptosis facilitator), BCL-G, BCLGbcl2-L-14
Symbole de gène(s)BCL2L14
Type de produitBcl G
Quantité0.05 mg
État réglementaireRUO - research use only
SourceSynthetic
Consigne15 amino acids near the carboxy terminus of human Bcl-G
Une question, une configuration particulière ?
Contactez-nous pour un devis.